These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 32631465)

  • 1. Neither protective nor harmonized: the crossborder regulation of medical devices in the EU.
    Jarman H; Rozenblum S; Huang TJ
    Health Econ Policy Law; 2021 Jan; 16(1):51-63. PubMed ID: 32631465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Legal regulation of the production and trade of medical devices and medical equipment in the EU and US: experience for Ukraine.
    Pashkov V; Kotvitska A; Harkusha A
    Wiad Lek; 2017; 70(3 pt 2):614-618. PubMed ID: 28713093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EU and member state medical devices regulation.
    Altenstetter C
    Int J Technol Assess Health Care; 2003; 19(1):228-48. PubMed ID: 12701954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Introduction of innovative high-risk medical devices in Europe: are clinical efficacy and safety guaranteed?].
    Stordeur S; Vinck I; Neyt M; Van Brabandt H; Hulstaert F
    Rev Epidemiol Sante Publique; 2013 Apr; 61(2):105-10. PubMed ID: 23477881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory clearance: How are outcome measurements critical?
    Fink M; Akra B
    Injury; 2020 May; 51 Suppl 2():S67-S70. PubMed ID: 31703963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advertising of medical devices: foreign experience and Ukrainian practice.
    Pashkov V; Harkusha A; Bytiak O
    Wiad Lek; 2017; 70(3 pt 1):456-461. PubMed ID: 28711887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How does medical device regulation perform in the United States and the European union? A systematic review.
    Kramer DB; Xu S; Kesselheim AS
    PLoS Med; 2012; 9(7):e1001276. PubMed ID: 22912563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EU postmarket surveillance plans for medical devices.
    Pane J; Francisca RDC; Verhamme KMC; Orozco M; Viroux H; Rebollo I; Sturkenboom MCJM
    Pharmacoepidemiol Drug Saf; 2019 Sep; 28(9):1155-1165. PubMed ID: 31318470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post market surveillance in the german medical device sector - current state and future perspectives.
    Zippel C; Bohnet-Joschko S
    Health Policy; 2017 Aug; 121(8):880-886. PubMed ID: 28697849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contraceptive devices and the medical devices directive.
    Austin A
    Br J Fam Plann; 2000 Jan; 26(1):56. PubMed ID: 10781970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical devices industry: the problem of clinical evaluation reports].
    Egbosimba D
    Ann Biol Clin (Paris); 2019 Oct; 77(5):514-516. PubMed ID: 31466939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of rates of safety issues and reporting of trial outcomes for medical devices approved in the European Union and United States: cohort study.
    Hwang TJ; Sokolov E; Franklin JM; Kesselheim AS
    BMJ; 2016 Jun; 353():i3323. PubMed ID: 27352914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The issues of development and functioning of common market of medical equipment and articles within the framework of the Eurasian Economic Union].
    Tonkonog VV
    Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med; 2024 Jul; 32(4):778-784. PubMed ID: 39158875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The metrology of medical devices for the diagnostic in vitro: the European approach].
    Antonov VS
    Klin Lab Diagn; 2011 Dec; (12):48-9. PubMed ID: 22416434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations for an institution for evaluation of diabetes technology devices to improve their quality in the European Union.
    Heinemann L; Freckmann G; Koschinsky T
    J Diabetes Sci Technol; 2013 Mar; 7(2):542-7. PubMed ID: 23567012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
    Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
    Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health.
    Bates C; Fagerström K; Jarvis MJ; Kunze M; McNeill A; Ramström L
    Tob Control; 2003 Dec; 12(4):360-7. PubMed ID: 14660767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generating appropriate clinical data for value assessment of medical devices: what role does regulation play?
    Tarricone R; Torbica A; Ferré F; Drummond M
    Expert Rev Pharmacoecon Outcomes Res; 2014 Oct; 14(5):707-18. PubMed ID: 25196848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A full-fledged overhaul is needed for a risk and value-based regulation of medical devices in Europe.
    Campillo-Artero C
    Health Policy; 2013 Nov; 113(1-2):38-44. PubMed ID: 23602548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical Device Regulation: Requirements for Dental Professionals Who Prescribe and Manufacture Custom-Made Devices.
    Green JIJ
    Prim Dent J; 2021 Mar; 10(1):64-88. PubMed ID: 33722134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.